Svmuu News: OP Labs, the infrastructure developer behind Optimism, announced a reduction of 20 employees, accounting for approximately 19.6% of its total team. In an internal letter, Jing Wang, Co-founder of Optimism and CEO of OP Labs, explicitly stated that this layoff is not due to financial pressure. The company currently has sufficient funds and multiple years of cash flow reserves. This move aims to "streamline operations, accelerate decision-making, and reduce collaboration costs."
Optimism is currently in a transition period. Last month, Base, the largest chain in the OP Stack ecosystem, announced it would transition to a self-developed unified tech stack. This change had raised market concerns about Optimism's long-term sustainability, causing the OP token price to drop by about 37% over the past 30 days. Despite the challenges, OP Labs has outlined a 2026 roadmap, focusing on faster block times, native interoperability, customizable compliance controls, and a Zero-Knowledge (ZK) Proof system aligned with the Ethereum roadmap. Additionally, OP token holders have previously passed a proposal to allocate 50% of Superchain sequencer revenue for token buybacks. (The Block)
OP Labs Cuts 20% of Staff to Focus on Core Business: Not Due to Financial Pressure
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
3
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
4
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
5
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
6
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
7
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
8
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
9
Iran-linked exchange Shelbit allegedly sent $676 million to Binance in sanctions-evasion operation, Reuters reports
-
10
NVIDIA and AMD: The Two Giants of AI Computing Power in 2026—An Analysis of Market Dynamics, Financial Performance, and Opportunities for Transition into Cryptocurrency Mining
Markets Today
Recommended Reading









